Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Cancer Letters|November 28, 2006
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistanceAnamaria Brozovic, Maja OsmakCritical Reviews in Toxicology|February 19, 2010
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatinAnamaria Brozovic, Andreja Ambriović-Ristov, Maja OsmakNeuroimmunomodulation|December 14, 2002
Serotonin and apoptosis: studies on rat lymphocytesJasminka Stefulj, Sanjica Jakopec, Maja Osmak, et al.Acta Chimica Slovenica|June 19, 2015
An axial chirality and disorder of positional isomers in a crystal of highly cytotoxic 3-acetyl-1,3-bis(2-chloro-4-nitrophenyl)-1E-triazeneKrešimir Molčanov, Slovenko Polanc, Maja Osmak, et al.Cancer Letters|March 23, 2010
Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cellsTamara Cimbora-Zovko, Gerhard Fritz, Nevenka Mikac, et al.Pharmacology & Toxicology|February 7, 2003
Diazenecarboxamide UP-91, a potential anticancer agent, acts by reducing cellular glutathione contentDubravka Moskatelo, Slovenko Polanc, Janez Kosmrlj, et al.International Journal of Cancer|May 18, 2004
Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptorAndreja Ambriović-Ristov, Jelka Gabrilovac, Tamara Cimbora-Zovko, et al.European Journal of Pharmacology|January 20, 2007
Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistanceTamara Cimbora-Zovko, Andreja Ambriović-Ristov, Jadranka Loncarek, et al.Gynecologic Oncology|October 8, 2003
Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomasSumski Simaga, Damir Babić, Maja Osmak, et al.Pageof 5